IN2014MN01552A - - Google Patents
Info
- Publication number
- IN2014MN01552A IN2014MN01552A IN1552MUN2014A IN2014MN01552A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A IN 1552MUN2014 A IN1552MUN2014 A IN 1552MUN2014A IN 2014MN01552 A IN2014MN01552 A IN 2014MN01552A
- Authority
- IN
- India
- Prior art keywords
- geranylgeranylacetone
- alone
- mixture
- retinal diseases
- retinal
- Prior art date
Links
- DJAHKBBSJCDSOZ-AJLBTXRUSA-N (5z,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one;(5e,9e,13e)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C/CCC(C)=O.CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\CCC(C)=O DJAHKBBSJCDSOZ-AJLBTXRUSA-N 0.000 abstract 6
- 229950006156 teprenone Drugs 0.000 abstract 6
- 208000017442 Retinal disease Diseases 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000030833 cell death Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000002207 retinal effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/121—Ketones acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012040803 | 2012-02-27 | ||
| PCT/JP2013/054774 WO2013129315A1 (ja) | 2012-02-27 | 2013-02-25 | 網膜疾患の予防、改善、又は治療剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01552A true IN2014MN01552A (enrdf_load_stackoverflow) | 2015-05-08 |
Family
ID=49082513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1552MUN2014 IN2014MN01552A (enrdf_load_stackoverflow) | 2012-02-27 | 2013-02-25 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130303625A1 (enrdf_load_stackoverflow) |
| JP (2) | JP5345744B1 (enrdf_load_stackoverflow) |
| CN (1) | CN104136015B (enrdf_load_stackoverflow) |
| IN (1) | IN2014MN01552A (enrdf_load_stackoverflow) |
| TW (1) | TWI566771B (enrdf_load_stackoverflow) |
| WO (1) | WO2013129315A1 (enrdf_load_stackoverflow) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130303625A1 (en) | 2012-02-27 | 2013-11-14 | Rohto Pharmaceutical Co., Ltd. | Agent for the prevention, improvement or treatment of retinal disease |
| WO2014129466A1 (ja) * | 2013-02-19 | 2014-08-28 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療用粘膜適用剤 |
| WO2015029925A1 (ja) * | 2013-08-26 | 2015-03-05 | ロート製薬株式会社 | 網膜疾患の予防、改善、又は治療剤 |
| WO2015129809A1 (ja) * | 2014-02-28 | 2015-09-03 | 国立大学法人京都大学 | 虚血性眼疾患の処置用の医薬組成物 |
| CN108998006B (zh) * | 2018-07-20 | 2021-06-08 | 合肥工业大学 | 一种环境友好的应变响应型荧光超分子材料及其制备方法 |
| US11154540B2 (en) * | 2018-10-19 | 2021-10-26 | Medicinova, Inc. | Methods of treating ophthalmic disease/disorder or injury with ibudilast |
| CN109470534B (zh) * | 2018-11-12 | 2021-05-25 | 山东骏腾医疗科技有限公司 | 一种病理组织透明脱蜡液及其制备方法 |
| CN109675038A (zh) * | 2019-02-01 | 2019-04-26 | 杭州赫尔斯科技有限公司 | 增强低浓度阿托品类药物安全性和临床疗效的组合物 |
| CN119792302B (zh) * | 2025-03-14 | 2025-06-24 | 山东师范大学 | 前列腺素e2在制备治疗蓝光暴露引发的视网膜损伤的药物中的应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06192073A (ja) * | 1992-12-24 | 1994-07-12 | Eisai Co Ltd | 細胞分化誘導剤 |
| JP3560072B2 (ja) | 1994-05-20 | 2004-09-02 | エーザイ株式会社 | 外用基剤 |
| JPH08133967A (ja) * | 1994-11-02 | 1996-05-28 | Eisai Co Ltd | ドライアイ治療剤 |
| JP2000319170A (ja) | 1999-03-05 | 2000-11-21 | Eisai Co Ltd | テプレノン含有点眼剤 |
| US20050009772A1 (en) * | 2003-05-06 | 2005-01-13 | The Regents Of The University Of California | Methods and compositions for the treatment of glaucoma and other retinal diseases |
| BRPI0615974A2 (pt) * | 2005-07-27 | 2011-05-31 | Univ Florida | uso de choque térmico para tratar uma doença ocular em um indivìduo, método para recrutar uma célula-tronco para um tecido ocular de um indivìduo com necessidade da mesma, uso de choque térmico para tratar uma doença ou um distúrbio ocular em um indivìduo com necessidade do mesmo, uso de choque térmico para regenerar a retina em um indivìduo com necessidade do mesmo, uso de choque térmico para reparar os danos ao epitélio pgmentar da retina em um indivìduo com necessidade do mesmo, uso de choque térmico para tratar a degeneração macular em um indivìduo com necessidade do mesmo, composição farmacêutica para o recrutamento de células-tronco, composição farmacêutica para recrutamento de células-tronco em um tecido ocular, kit e método para identificar um agente que aumenta o recrutamento de células-tronco em um tecido ocular |
| AU2006272497B2 (en) | 2005-07-27 | 2012-07-19 | University Of Florida Research Foundation, Inc. | Small compounds that correct protein misfolding and uses thereof |
| CN103052619A (zh) * | 2010-09-01 | 2013-04-17 | 科约特制药公司 | 治疗神经退行性疾病的方法 |
| US20130303625A1 (en) | 2012-02-27 | 2013-11-14 | Rohto Pharmaceutical Co., Ltd. | Agent for the prevention, improvement or treatment of retinal disease |
-
2013
- 2013-02-25 US US13/775,605 patent/US20130303625A1/en not_active Abandoned
- 2013-02-25 TW TW102106505A patent/TWI566771B/zh not_active IP Right Cessation
- 2013-02-25 CN CN201380011312.6A patent/CN104136015B/zh not_active Expired - Fee Related
- 2013-02-25 WO PCT/JP2013/054774 patent/WO2013129315A1/ja active Application Filing
- 2013-02-25 IN IN1552MUN2014 patent/IN2014MN01552A/en unknown
- 2013-02-25 JP JP2013510415A patent/JP5345744B1/ja active Active
- 2013-07-12 JP JP2013146970A patent/JP2013213049A/ja active Pending
-
2014
- 2014-01-14 US US14/154,688 patent/US9724312B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| TWI566771B (zh) | 2017-01-21 |
| CN104136015A (zh) | 2014-11-05 |
| JPWO2013129315A1 (ja) | 2015-07-30 |
| JP2013213049A (ja) | 2013-10-17 |
| US20130303625A1 (en) | 2013-11-14 |
| TW201338771A (zh) | 2013-10-01 |
| US9724312B2 (en) | 2017-08-08 |
| US20140128475A1 (en) | 2014-05-08 |
| WO2013129315A1 (ja) | 2013-09-06 |
| JP5345744B1 (ja) | 2013-11-20 |
| HK1200111A1 (en) | 2015-07-31 |
| CN104136015B (zh) | 2016-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01552A (enrdf_load_stackoverflow) | ||
| PH12014501718A1 (en) | Novel therapeutic agents | |
| PH12016500216B1 (en) | Stable pharmaceutical composition and methods of using same | |
| MX370903B (es) | Composiciones de ácido percarboxílico estables y sus usos. | |
| PH12014501656B1 (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
| MY185016A (en) | Progenitor cells of mesodermal lineage | |
| MX2013008192A (es) | Inhibidores de bace-2 para tratamiento de transtornos metabolicos. | |
| IN2014DN06104A (enrdf_load_stackoverflow) | ||
| MX2015013275A (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevencion de enfermedades o afecciones asociadas con difucion mitocondrial. | |
| BR112014015342A2 (pt) | células-tronco pluripotentes induzidas de células derivadas do tecido do cordão umbilical humano | |
| PH12014502805A1 (en) | Novel indanesulfamide derivative | |
| MX359002B (es) | Metodo y composicion para prevenir la interrupcion y agregacion de celulas madre. | |
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| MY171048A (en) | Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions | |
| IN2014MN01551A (enrdf_load_stackoverflow) | ||
| PH12015501561A1 (en) | Method of treatment of diseases | |
| PH12013502563A1 (en) | Dha and epa in the reduction of oxidative stress | |
| PH12013501896A1 (en) | Use of a sprayable composition comprising ambroxol | |
| WO2014005153A3 (en) | Methods for treating mds1-evi1 mediated cancer | |
| PH12015501109A1 (en) | Novel compounds as diacylglycerol acyltransferase inhibitors | |
| NZ612843A (en) | Pheromone composition | |
| MX342186B (es) | Concentrado alimenticio en forma de gel, y proceso para prepararlo. | |
| MX337593B (es) | Gemcabeno y derivados para tratar la pancreatitis. | |
| MX353587B (es) | Formulaciones farmacéuticas que contienen ipidacrina y su uso para el tratamiento de trastornos de potencia y trastornos de otras formas de actividad sexual. | |
| UA59871U (ru) | Способ ликвидации последствий фосфорной аварии и нейтрализации желтого фосфора |